| Literature DB >> 34066603 |
Yolanda Nadal-Nicolás1, Laura Miralles-Amorós2, María Martínez-Olcina2, María Sánchez-Ortega2, Juan Mora2, Alejandro Martínez-Rodríguez2,3.
Abstract
Fibromyalgia (FM) is a chronic non-degenerative disease characterized by the presence of multiple symptoms such as chronic pain, which negatively influence the quality of life of sufferers, most of whom are women. Currently, there is no effective treatment to limit the impact of these symptoms. The aim of this research is to review the scientific evidence on the effect of following a vegetarian or vegan diet on fibromyalgia patients. A systematic review included the original articles that answered the research question. These articles were in 2021 in the PubMed, Web of Science and Scopus databases. The research used the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. No time restriction was applied, and grey literature was not included. The evaluation of the methodological quality of the articles was carried out using the following different scales: STROBE (strengthening the reporting of observational studies in epidemiology), PEDro (Physiotherapy Evidence Database), and MMAT (Mixed Methods Appraisal Tool) scales. A total of 88 studies were analyzed, of which 6 investigations were included in this systematic review (n = 4 clinical trials and n = 2 cohort studies). These investigations show significant improvements in biochemical parameters, quality of life, quality of sleep, pain at rest and general health status when following mainly plant-based dietary patterns. In conclusion, these findings are promising but interpretation of the findings is limited due to the methodological quality of the studies. Well-designed clinical trials are needed to consolidate these dietary recommendations in FM patients.Entities:
Keywords: chronic diseases; diet therapy; dietary supplements; fibromyalgia; nutrition; public health; veganism; vegetarian diet
Year: 2021 PMID: 34066603 PMCID: PMC8125538 DOI: 10.3390/ijerph18094955
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1PRISMA diagram: Flowchart of study section process.
Vegetarian or vegan interventions in fibromyalgia patients.
| Study | Type of Study | Participants | Interventions | Results |
|---|---|---|---|---|
| Kaartinen K, 2000 [ | Clinical trial | 28 females with FM (average age 51–52 years); intervention group ( |
Intervention group: “LF diet” (vegan diet with all food uncooked). Supplement of vitamin B12. Control group: Unrestricted diet |
Laboratory parameters—cholesterol, ESR, hematocrit: improvement in serum cholesterol in the LF group. No significant changes in ESR or hematocrit in either group. Body weight: significant decrease in body weight and therefore BMI in the LF group. Clinical controls and BDI: no significant differences in either group. Resting pain: significant decrease in the LF group. FM symptoms: improvement in sleep quality, reduction in morning stiffness, improvement in general health questionnaire, improvement in health assessment questionnaire and in rheumatologist’s global questionnaire in the LF group. Exercise test and handgrip power: no significant changes in any group. |
| Donaldson M S, 2001 [ | Observational cohort study | 30 persons with FM (28 female and 2 male) (average 45–54 years) |
Pure vegetarian diet mainly raw |
Physical performance: significant improvements. Hand grip strength: significantly decreased. Impact of FM (FIQ): significantly reduced. Quality of life (QOLS): significant improvements in active recreation, health, socialization, and participation in organizations. Health Survey (SF-36): Significant improvement in physical functioning, physical role, general health, vitality, social functioning, emotional role, and mental health, except in bodily pain. Significant improvement in 7 of these 8 areas, with bodily pain being the exception. |
| Martínez-Rodríguez A, 2018 [ | Randomized clinical trial | 21 females with FM (34 ± 3 years) |
Intervention group A ( Intervention group B ( Control group C ( |
Body composition: fat-free mass increased significantly in group A, no differences were found in group B and there was a significant decrease in group C. Fat mass decreased significantly in group A, was unchanged in group B and increased significantly in group C. VAS scale: decreased significantly in group A, no significant change was found in group B and increased in group C. |
| Michalsen A, 2005 [ | Observational cohort study | 51 patients with RA (9 female) or FM (32 female and 3 male). The 4 groups: FM and fasting ( |
Fasting intervention. Diet intervention: normocaloric mostly vegetarian modified whole grain Mediterranean diet. Additional treatments: physical exercise, physiotherapy, stress program and different concomitant therapies such as hydrotherapy and massage for all participants. |
Body weight: decreased in fasting patients compared to patients on a vegetarian diet. Symptom severity: no significant variation among FM patients. Stool analysis: no significant change in either group. |
| Hanninen O, 2000 [ | Clinical trial | 115 persons: 40 healthy volunteered, 33 FM patients, 42 RA subjects. They were divided into LF and omnivorous controls |
“LF diet” (uncooked vegan diet) Control (omnivorous diet) |
Antioxidant and lignan levels: significantly increased in subjects on the LF diet. Rheumatoid symptoms: Significant subjective and objective relief of symptoms with the LF diet. Improvement on joint stiffness and general health status. VAS scale: significant differences were found, subjects who adopted the LF diet improved the punctuation in this scale. |
| Hostmark A T, 1991 [ | Clinical trial | 8 female and 2 males with FM (49.9 ± 4.1 years) |
Vegetarian diet |
Body weight: significantly decreased. Well-being: no significant differences were found, although 7 participants did improve subjectively. Laboratory parameters—cholesterol, peroxides, fibrinogen, triacylglycerol: Significant decrease in serum peroxides, plasma fibrinogen concentration, serum total cholesterol and apolipoprotein A and B levels. There was no significant alteration in mean serum triacylglycerol concentration. |
BDI: Beck depression inventories; BMI: body mass index; ESR: erythrocyte sedimentation rate; FIQ: fibromyalgia impact questionnaire; FM: fibromyalgia; LF: living food; QOLS: quality of life survey; RA: rheumatoid arthritis; SF-36: short form health survey; VAS: visual analogue scale.